Deutsche Zeitschrift für Onkologie 2011; 43(3): 112-118
DOI: 10.1055/s-0030-1257668
Forschung
© Karl F. Haug Verlag MVS Medizinverlage Stuttgart GmbH & Co. KG

Krebsstammzellen und ihre Nische als Lebensquelle des Todes

Ludwig Manfred Jacob
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
21. Oktober 2011 (online)

Zusammenfassung

Das bisherige Konzept der Kanzerogenese hat seine Berechtigung, jedoch ist es in wesentlichen Teilen inkomplett. Gestörte Zellsignal- und Zellkommunikationswege rücken in den Fokus der Forschung. Durch ihre Fähigkeit der unbegrenzten Selbsterneuerung und Apoptoseresistenz kommt Krebsstammzellen eine zentrale Rolle zu, die in der Krebstherapie noch keine Berücksichtigung findet. Die Nische („microenvironment“) nimmt entscheidenden Einfluss auf die Krebsentwicklung. Dieses relativ neue Konzept weist viele Parallelen mit dem Konzept von Tumormilieu und Grundsubstanz auf, das aus den Arbeiten von Pischinger und Heine bekannt ist. Behandlungsverfahren, die gezielt gegen Tumorstammzellen gerichtet sind, könnten den eigentlichen Motor der Krankheit zerstören, während eine Therapie des Tumormilieus dem Tumor den Wachstumsboden entzieht. Dabei kommt Bewegung/Sport und dem Säure-Basen-Haushalt eine besondere Bedeutung zu.

Summary

The current concept of the cancerogenesis has his authorization, though incomplete in essential aspects. Next to disorders in cellular pathways and cell communication cancer stem cells play a major role as they have the ability of unlimited self renewal and apoptosis resistance. Nevertheless, the present cancer therapy does not target cancer stem cells. Also, the microenvironment is able to influence the cancerogenesis decisively. This concept is relatively new and exhibits multiple parallels with the concept of the tumor milieu and the extracellular matrix, which is known from the work of Pischinger und Heine. Therapies targeting tumor stem cells would be able to destroy the ultimate engine of the disease, whilst the therapy of the tumor milieu deprives the cancer of its breeding ground. In this context physical exercise and the acid-base balance are of particular importance.

 
  • Literatur

  • 1 Al-Hajj M, Wicha MS, Benito-Hernandez A et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-3988
  • 2 Barcellos-Hoff MH, Ravani SA. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 2000; 60: 1254-1260
  • 3 Bhatia R, Holtz M, Niu N et al. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood 2003; 101: 4701-4707
  • 4 Birnie R, Bryce SD, Roome C et al. Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions. Genome Biol 2008; 9 (5) Epub 2008 May 20
  • 5 Bissell MJ, Labarge MA. Context, tissue plasticity, and cancer: Are tumor stem cells also regulated by the microenvironment?. Cancer Cell 2005; 7: 17-23
  • 6 Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730-737
  • 7 Chin K, de Solorzano CO, Knowles D et al. In situ analyses of genome instability in breast cancer. Nat Genet 2004; 36: 984-988
  • 8 Cohen RM, Stephenson RL, Feldman GM. Bicarbonate secretion modulates ammonium absorption in rat distal colon in vivo. Am J Physiol Renal Physiol 1998; 254: 657-67
  • 9 Collins AT, Berry PA, Hyde C et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65: 10946-10951
  • 10 Danner BC, Didilis VN, Wiemeyer S, Stojanovic T, Kitz J, Emmert A, Füzesi L, Schöndube FA. Long-term survival is linked to serum LDH and partly to tumour LDH-5 in NSCLC. Anticancer Res 2010; 30 (4): 1347-51
  • 11 Dolberg DS, Hollingsworth R, Hertle M, Bissell MJ. Wounding and its role in RSV-mediated tumor formation. Science 1985; 230: 676-678
  • 12 Galli R, Binda E, Orfarelli U et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004; 64: 7011-7021
  • 13 Graham SM, Jørgensen HG, Allan E et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 2002; 99: 319-325
  • 14 Griffin JD. Leukemia stem cells and constitutive activation of NFkappaB. Blood 2001; 98 (8): 2291-2291
  • 15 Gu G, Yuan J, Wills M, Kasper S. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 2007; 67: 4807-4815
  • 16 Guzman ML, Swiderski CF, Howard DS et al. Preferential induction of apoptosis for primary human leukemic stem cells. Proc Natl Acad Sci USA 2002; 99: 16220-16225
  • 17 Harguindey S, Arranz JL, Wahl ML et al. Proton transport inhibitors as potentially selective anticancer drugs. Anticancer Res 2009; 29 (6): 2127-36
  • 18 Hemmati HD, Nakano I, Lazareff JA et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 2003; 100: 15178-15183
  • 19 Hochedlinger K, Blelloch R, Brennan C et al. Reprogramming of a melanoma genome by nuclear transplantation. Genes Dev 2004; 18: 1875-1885
  • 20 Hope KJ, Jin L, Dick JE. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 2004; 5: 738-743
  • 21 Houghton J, Stoicov C, Nomura S et al. Gastric cancer originating from bone marrow-derived cells. Science 2004; 306: 1568-71
  • 22 Howe JR, Roth S, Ringold JC et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998; 280: 1086-1088
  • 23 Jones RJ, Matsui WH, Smith BD. Cancer stem cells: are we missing the target?. J Natl Cancer Inst 2004; 96: 583-585
  • 24 Kawaii S, Lansky EP. Differentiation-promoting activity of pomegranate (Punica granatum) fruit extracts in HL-60 human promyelocytic leukemia cells. J Medicinal Food 2004; 7: 13-18
  • 25 Kenny PA, Bissell MJ. Tumor reversion: Correction of malignant behavior by microenvironmental cues. Int J Cancer 2003; 107: 688-695
  • 26 Kim CF, Jackson EL, Woolfenden AE et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005; 121: 823-835
  • 27 Koukourakis MI, Giatromanolaki A, Winter S, Leek R, Sivridis E, Harris AL. Lactate dehydrogenase 5 expression in squamous cell head and neck cancer relates to prognosis following radical or postoperative radiotherapy. Oncology 2009; 77 (5): 285-92 Epub 2009 Nov 16
  • 28 Lapidot T, Sirard C, Vormoor J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645-648
  • 29 Li C, Heidt DG, Dalerba P et al. Identification of pancreatic cancer stem cells. Cancer Res 2007; 67: 1030-1037
  • 30 Litvinov IV, De Marzo AM, Isaacs JT. Is the Achilles‘ heel for prostate cancer therapy a gain of function in androgen receptor signaling?. J Clin Endocrinol Metab 2003; 88: 2972-2982
  • 31 Mayer A, von Wallbrunn A, Vaupel P. Glucose metabolism of malignant cells is not regulated by transketolase-like (TKTL)-1. Int J Oncol 2010; 37(2): 265-71
  • 32 Milford J, Duran-Reynals F. Growth of a chicken sarcoma virus in the chick embryo in the absence of neoplasia. Cancer Res 1943; 3: 578-584
  • 33 Mintz B, llmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci USA 1975; 72: 3585-3589
  • 34 Monzani E, Facchetti F, Galmozzi E et al. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 2007; 43: 935-946
  • 35 O’Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106-110
  • 36 Patel AA, Gawlinski ET, Lemieux SK, Gatenby RA. A cellular automaton model of early tumor growth and invasion. J Theor Biol 2001; 213 (3): 315-31
  • 37 Potten CS, Wilson JW, Booth C. Regulation and significance of apoptosis in the stem cells of the gastrointestinal epithelium. Stem Cells 1997; 15 (2): 82-93
  • 38 Prince ME, Sivanandan R, Kaczorowski A et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 2007; 104: 973-978
  • 39 Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-111
  • 40 Ricci-Vitiani L, Lombardi DG, Pilozzi E et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-115
  • 41 Rous P. A transmissible avian neoplasm. (Sarcoma of the common fowl). J Exp Med 1979; 150: 738-753
  • 42 Santel T, Pflug G, Hemdan NY et al. Curcumin inhibits glyoxalase 1: a possible link to its anti-inflammatory and antitumor activity. PLoS ONE 2008; 3: e3508
  • 43 Sieweke MH, Bissell MJ. The tumor-promoting effect of wounding: A possible role for TGF-beta-induced stromal alterations. Crit Rev Oncog 1994; 5: 297-311
  • 44 Sieweke MH, Thompson NL, Sporn MB, Bissell MJ. Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta. Science 1990; 248: 1656-1660
  • 45 Singh SK, Clarke ID, Terasaki M et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-5828
  • 46 Singh SK, Hawkins C, Clarke ID et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401
  • 47 Smallbone K, Maini PK, Gatenby RA. Episodic, transient systemic acidosis delays evolution of the malignant phenotype: Possible mechanism for cancer prevention by increased physical activity. Biol Direct 2010; 5: 22
  • 48 Sternlicht MD, Lochter A, Sympson CJ et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 1999; 98: 137-146
  • 49 Stoker AW, Hatier C, Bissell MJ. The embryonic environment strongly attenuates v-src oncogenesis in mesenchymal and epithelial tissues, but not in endothelia. J. Cell Biol 1990; 111: 217-228
  • 50 Takeuchi M, Kimura S, Kuroda J et al. Glyoxalase-I is a novel target against Bcr-Abl+ leukemic cells acquiring stem-like characteristics in a hypoxic environment. Cell Death Differ 2010; 17 (7): 1211-20
  • 51 Walenta S, Mueller-Klieser WF. Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol 2004; 14 (3): 267-74
  • 52 Walenta S, Wetterling M, Lehrke M et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 2000; 60: 916-21